Avatar-Directed Chemotherapy in Platinum-Resistant Ovarian, Primary Peritoneal and Fallopian Tube Cancers
Phase of Trial: Phase II
Latest Information Update: 04 Jul 2017
At a glance
- Drugs Doxorubicin liposomal (Primary) ; Gemcitabine (Primary) ; Paclitaxel (Primary) ; Topotecan (Primary)
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- 23 Jun 2016 Planned number of patients changed from 60 to 240.
- 04 Dec 2015 Planned primary completion date changed from 1 Jun 2018 to 1 Jun 2020 as per ClinicalTrials.gov record.
- 22 Jul 2015 Status changed from not yet recruiting to recruiting as per ClinicalTrials.gov record.